Affluent Medical SA (FR:AFME) has released an update.
Affluent Medical, a French MedTech company, has disclosed its share capital and voting rights as of March 31, 2024, revealing a total of 33,145,609 shares and 49,275,529 theoretical voting rights. The company, known for developing next-generation minimally invasive implants for structural heart diseases and urinary incontinence, is preparing for the potential commercial launch of its products in early 2026, pending successful financing and clinical studies.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
